Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Has results × Advanced Breast Cancer × Goserelin × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Prostatic Neoplasms 44 Breast Neoplasms 23 Neoplasms 5 Neoplasm Metastasis 3 Breast Neoplasms, Male 2 Recurrence 1 Prostate Adenocarcinoma 1 Primary Ovarian Insufficiency 1 PSA Level Greater Than Two 1 Osteitis Deformans 1 Lymphatic Metastasis 1 Infertility 1 Hormone-sensitive Metastatic Breast Cancer 1 Hereditary Sensory and Autonomic Neuropathies 1 Advanced Metastatic Breast Cancer 1 Advanced Breast Cancer 1

Interventions

Fulvestrant 3 Docetaxel 2 Dasatinib 2 vandetanib 1 sonidegib 1 palbociclib 1 olaparib 1 exemestane 1 cediranib 1 Letrozole 1 Goserelin 1 Everolimus 1 Capecitabine 1 Alpelisib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04862143 2024-06-20

TELEPIK

Novartis

Phase 2 Terminated

2 enrolled 10 charts

Advanced Breast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡